Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck, Bristol drugs show longer survival for deadly cancers
Merck, Bristol drugs show longer survival for deadly cancers
Merck, Bristol drugs show longer survival for deadly cancers
Submitted by
admin
on May 19, 2016 - 9:59am
Source:
Yahoo/Reuters
News Tags:
Merck
Bristol-Myers Squibb
cancer immunotherapy
lung cancer
melanoma
Opdivo
Keytruda
ASCO 2016
Headline:
Merck, Bristol drugs show longer survival for deadly cancers
Do Not Allow Advertisers to Use My Personal information
